Grants and Contributions:
Title:
Artifact rejection for improved measurement reporting of vital signs
Agreement Number:
1006798
Agreement Value:
$393,000.00
Agreement Date:
May 15, 2023 - Mar 31, 2024
Description:
BRAEBON has developed a prototype remote vital signs patient monitoring system which can report back EKG, Heart Rate, SpO2, Pulse Rate, Breathing Rate, Temperature and Activity. The system’s accuracy is currently compromised by artifacts in the raw signal. This project will address these artifacts which are specific to each of the raw signals so a reliable, accurate measurement can always be generated in the normal remote operating environment during normal everyday activities.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Kanata, Ontario, CA K2K 1Y2
Reference Number:
172-2023-2024-Q1-1006798
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
869502567
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Nov 8, 2023
Recipient's Legal Name:
Braebon Medical Corporation
Federal Riding Name:
Kanata--Carleton
Federal Riding Number:
35041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: